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Abstract
Background: Complementary and Alternative Medicine (CAM) is widely used and popular among patients with
primary headache or low back pain (LBP). Aim of the study was to analyze attitudes of headache and LBP patients
towards the use of CAM.
Methods: Two questionnaire-based surveys were applied comparing 432 primary headache and 194 LBP patients.
Results: In total, 84.75% of all patients reported use of CAM; with significantly more LBP patients. The most
frequently-used CAM therapies in headache were acupuncture (71.4%), massages (56.4%), and thermotherapy
(29.2%), in LBP thermotherapy (77.4%), massages (62.7%), and acupuncture (51.4%). The most frequent attitudes
towards CAM use in headache vs. LBP: “leave nothing undone” (62.5% vs. 52.1%; p = 0.006), “take action against
the disease” (56.8% vs. 43.2%; p = 0.006). Nearly all patients with previous experience with CAM currently use CAM
in both conditions (93.6% in headache; 100% in LBP). However, the majority of the patients had no previous
experience.
Conclusion: Understanding motivations for CAM treatment is important, because attitudes derive from wishes for
non-pharmacological treatment, to be more involved in treatment and avoid side effects. Despite higher age and
more permanent pain in LBP, both groups show high use of CAM with only little specific difference in preferred
methods and attitudes towards CAM use. This may reflect deficits and unfulfilled goals in conventional treatment.
Maybe CAM can decrease the gap between patients’ expectations about pain therapy and treatment reality,
considering that both conditions are often chronic diseases, causing high burdens for daily life.
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Background
Low back pain (LBP) and primary headache disorders
are frequent pain conditions at risk of chronification.
Both cause a high burden of disease, large impact on
social life and work capacity. The one-year prevalence of
LBP in Germany is 57% for males and 66% for females
[1]. The 6-month prevalence of primary headache is
about 43% [2]. Whereas primary headaches often persist
over decades, LBP becomes chronic only in some
patients [3,4]. Standard treatment includes acute pain-
relieving medication, whereas additional prophylactic
medication is recommended in frequent or chronic pain.
There is evidence for the effectiveness of non-pharma-
cological therapies like physiotherapy, aerobic exercise,
cognitive behavioral therapy, progressive muscle relaxa-
tion and biofeedback in both diseases [5-8]. Both head-
ache and LBP patients often avoid regular intake of
prophylactic medication.
CAM practitioners emphasize the holistic, individua-
listic, empowering, and educational nature of CAM [9].
Therefore, patients are very attentive to CAM, despite
the lack of evidence or possible side effects. Lifestyle fac-
tors like nutrition, smoking, consumption of alcohol,
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quency of CAM treatment. The use of CAM therapies
increased in the population from 33.8% to 42.1% in the
US from 1990 to 1997 and in Germany from 52% in
1970 to 65% in 1997 [10,11]. Likewise, the use of CAM
is increasing among neurological patients [12]. Despite
the growing number of publications on CAM, there is
no generally-accepted definition of CAM [13]. The (US)
National Center for Complementary and Alternative
Medicine (NCCAM) defines CAM as “a group of diverse
medical and health-care systems, practices, and products
that are not currently considered to be part of conven-
tional medicine” [14]. It was stated: “There is no alterna-
tive medicine. There is only scientifically proven,
evidence-based medicine supported by solid data or
unproven medicine, for which scientific evidence is lack-
ing”[15] Therefore, strict definitions of which therapies
are considered to be CAM, especially in headache or in
low back pain therapy, do not exist and may depend on
cultural background and health-system conditions.
Patients’ belief about the effectiveness of any therapy is
important in the field of CAM. Some therapies have
now been proven in clinical trials; others are based on
traditional theories and clinical experience. Data about
incidence and motivation of CAM use among headache
and LBP patients in Germany are rare. The study
focuses on three major questions: 1.) to evaluate the fre-
quency of CAM use among patients with two chronic
pain conditions (primary headache vs. low back pain),
2.) to compare the CAM modalities used by the two
diagnostic groups, and 3.) to analyze motivation for
CAM use in both diagnostic groups.
Methods
Study population
Four hundred forty-eight patients with primary head-
ache according to the criteria of the International Head-
ache Society (ICHD-II) were recruited consecutively in
seven tertiary headache centers in Germany and Austria
between July 2005 and December 2006 [16]. Diagnosis
was established by experienced neurologists in all
patients. Finally, 432 (96.4%) patients were included in
the analysis [17]. Additionally, 200 inpatients suffering
from low back pain (LBP), sciatica, and failed-back-sur-
gery syndrome (FBSS) were screened in two German
orthopedic departments; 194 could be included in the
study. Diagnosis was established by orthopedic specia-
lists following clinical findings. All patients attended
conservative pain therapy; no patient suffered from
acute LBP or underwent surgical treatment. Both studies
were approved by the Ethics Committee of the Faculty
of Medicine, Martin-Luther-University Halle-Witten-
berg. Written informed consent was obtained from all
patients.
Research instruments
The self administered questionnaire for the two groups
consisted of 42 items including socio-demographic and
socioeconomic data [18], information and pain-specific
data (e.g. beginning and history of disease, frequency of
pain, conventional therapies, and current medication).
The time for completing the questionnaire was not
longer than 30 minutes. Measurement of aspects of dis-
ability and burden of disease in headache patients was
d o n ew i t ht h eM i g r a i n eD i s a b i l i t yA s s e s s m e n tS c o r e
(MIDAS) [19]. For LBP, the Oswestry Low Back Pain
Disability Questionnaire Index (ODI) was used, which is
recommended for measurement of disability. Since the
ODI had not been translated and validated in German, a
backward-forward translation and a feasibility study was
done with 148 low-back-pain patients [20]. The ques-
tionnaire has since been validated for inpatients with
chronic LBP and the German version (ODI-G) shows a
very high level of test-retest-reliability and validity [21].
The study questionnaire included a list of possible CAM
treatments in headaches and LBP based on own experi-
ences and a literature search about frequently-used
modalities. This was a consequence of the lack of a gen-
erally-accepted definition of CAM in both conditions.
Patients could add further therapies at the end of the
list. However, not all therapies were comparable because
some CAM treatments are only used in headache or
LBP patients (for example kinesio-taping in LBP).
Patients were asked for lifetime experience with CAM.
Further questions focused on attitudes towards CAM
and barriers of CAM therapy. Results of both question-
naires were compared.
Statistics
Comparisons were primarily carried out between head-
ache and LBP patients and between patients who had
versus those who had not used CAM-treatments. Fre-
quency distributions of qualitative data were analyzed by
c
2 tests. Quantitative data were compared by Student’s
t-tests or Mann-Whitney U-tests, according to data dis-
tribution. The alpha level of significance was set at .05,
two-tailed and additionally Bonferroni adjusted accord-
ing to multiple comparisons. All computations were
made with SPSS13.0.
Results
Study population
Four hundred thirty-two patients were suffering from
headache and 194 from LBP. Demographic data are dis-
played in Table 1. Among headache patients, migraine
(78.5%), tension type headache (TTH) (19.0%), com-
bined migraine and TTH (7.4%), cluster headache or
other rare headaches (2.5%), and combined cluster head-
ache and migraine (0.5%) were reported. The LBP
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and FBSS (10%). Women were more often affected by
headache and LBP than men; in the headache group
this is mainly due to the majority of female migraineurs.
Educational level differs between headache and LBP.
Headache patients report lower educational level (with-
out vocational training) more frequently than LBP
patients. Contradicting this, more headache patients
than LBP patients hold a university degree. In both
patient groups invalidity rate was low with no statistical
difference (4% in headache vs. 6.9% in LBP).
Burden of disease and disability measurement
Burden of disease for both diseases is measured by the
items of MIDAS and ODI and further aspects with the
frequency of pain days, days with inability to work and
days with reduced functioning at work as well as in
social life and household (Table 2). LBP patients experi-
enced a significantly higher burden of disease and dis-
ability than headache patients, except in regard to pain
intensity which was similar in both patient groups.
Course of disease and treatment history
Duration of disease and duration of conventional and
CAM medical treatment are displayed in Table 3. The
frequency of previous use of CAM for treatment of dis-
eases other than headache and LBP showed no signifi-
cant difference between headache (18.9%) and LBP
patients (13.5%).
Use of CAM among headache and LBP patients
Overall, CAM was applied in 91.2% of LBP patients
compared to 81.7% in the headache group. Use was
similar for women (93.3% in LBP, 82.5% in headache)
and men (87.8% in LBP, 79.2% in headache). Regardless
of this high overall use, the difference between the two
diagnostic groups was significant (p = .002). Previous
experiences with CAM treatment for other diseases
were low and did not significant differ between head-
ache and LBP patients (18.9% vs. 13.5%; n.s.). The over-
whelming majority of patients with previous experience
of CAM use are currently CAM users for headache and
L B Pa sw e l l( 9 3 . 6 %i nh e a d a c h e ;1 0 0 %i nL B P ) .H o w -
ever, previous CAM use failed to predict current CAM
use when computed in a regression analysis due to the
small proportion of patients in both groups not fulfilling
t h ec r i t e r i ao fp r e v i o u sC A Mu s e .T h ed i s t r i b u t i o no f
different CAM treatments is displayed in Table 4.
The relationship between the burden of disease and
f r e q u e n c yo fC A Mu s ew a sc a l c u l a t e d .D u et oo v e r a l l
severe disability in the patient populations (64.2%
MIDAS severity score IV and 39.4% ODI-Score > 40) in
both patient groups, no significant differences regarding
CAM use could be detected.
Attitudes towards using CAM treatment
Reasons for CAM use differ between headache and LBP
patients (Figure 1). Reasons for not using CAM given by
the 79 non-using headache patients were ‘not heard
Table 1 Demographic characteristics
Headache (n = 432) LBP (n = 194) p value
Gender
a < .001
Male, n (%) 106 (24.5) 74 (38.1)
Female, n (%) 326 (75.5) 120 (61.9)
Age, mean (SD)
b 40.1 (13.8) 58.2 (14.3) < .001
Marital status
a < .001
Single, n (%) 132 (30.8) 8 (4.2)
Partnership, n (%) 254 (59.2) 123 (64.1)
Divorced/widowed, n (%) 43 (9.0) 61 (29.8)
Educational level
a < .001
No vocational training, n (%) 69 (16.3) 15 (8.2)
Vocational training, n (%) 250 (59.1) 141 (76.6)
University degree, n (%) 93 (22) 26 (14.1)
Other, n (%) 11 (2.6) 2 (1.1)
Employment statistics
a < .001
Fulltime work, n (%) 202 (47.5) 60 (31.9)
Parttime work, n (%) 81 (19.1) 13 (6.9)
Unemployed/housewife, n (%) 93 (21.9) 22 (11.7)
Pensioner, n (%) 32 (7.5) 80 (42.6)
Invalidity, n (%) 17 (4) 13 (6.9)
Family members by the same pain condition, n (%)
a 254 (60.3) 68 (37.6) < .001
ac2 test was run;
b t test was run
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interest’ (3.8%), other reasons (25.3%); 21% declared no
reasons at all for non-use. The non-CAM using group
in LBP consisted of only 17 patients. Only one patient
gave the reason ‘too expensive’,n o n eo ft h eo t h e r sg a v e
any specific reason.
Additional factors which may influence CAM use
Three hundred twenty patients reported membership in
a church (93 Lutheran, 206 Catholic, 19 others) while
272 did not. No significant association with CAM use
was found for membership in a church. CAM users are
more likely to live with a partner. 3.4% of the headache
and 1.8% of the LBP patients are vegetarians (n.s.). Due
to the small number, it is not possible to determine if
this lifestyle factor predicts CAM use. Additional life-
style information and factors which may influence CAM
use are displayed in Table 5. More patients using CAM
do not drink alcohol compared to non-users, whereas
no statistical differences were found for occasional and
daily alcohol consumption. Satisfaction with therapy was
analyzed among non-CAM and CAM users (Table 6).
Discussion
The high overall CAM use (87%) despite substantial dif-
ferences in disease-specific aspects of the two patient
populations revealed in the study is in line with popula-
tion-based findings showing frequent CAM use in LBP
(57%), cold (29%), headaches (19%), strain (15%) and
gastrointestinal ailments (12%) [22].
LBP and headache patients differ regarding demo-
g r a p h i cd a t a( T a b l e1 ) ,r e f l e c ting the characteristics of
the diseases (e.g. higher age and later onset in LBP),
which also can influence lifetime experience with CAM.
The educational level differs significantly with a higher
portion holding a university degree among headache
patients. This may have two reasons: 1. LBP patients are
older and education levels increased during the last dec-
ades 2. Patients with lower education are likely to do
manual work and therefore suffer more from LBP.
Duration of disease is significantly longer for headache
patients due to the onset of primary headache in adoles-
cence, whereas LBP mostly begins in middle-aged or
older people.
Patients with LBP were more likely unable to work
than headache patients. Headache patients suffer most
from episodic headache with only half the pain days per
month compared to LBP. Therefore, the intake of
analgesics in LBP is more than twice as high as for
headache patients. However, there were no differences
in mean pain intensity in the two groups. The signifi-
cantly higher number of affected family members in
headache compared to LBP (Table 1) reflects the genetic
background of primary headaches.
Chronic pain was found to double the odds of using
CAM [23]. A recent Canadian survey found migraine
and asthma as predictors for higher CAM use in the
population. However, this was not supported for other
chronic diseases with a rather constant nature of symp-
toms (significantly lower CAM use in diabetes, no sig-
nificant rate of CAM use compared to general
population in epilepsy) [24].
Conventional treatment often does not result in reso-
lution of symptoms; therefore patients look for alterna-
tive treatment options. In 2002, a population-based US
survey revealed that 6% of the population use CAM for
Table 2 Burden of disease
Headache
(N = 432)
LBP
(n = 194)
p
value
Days with pain within the last three months (mean/SD) 30.2 (27.2) 78.2 (22.4) < .001
Mean pain intensity (NRS 0-10/SD) 7.1 (1.8) 6.9 (2.0) n.s.
Lost work days within the last three months due to headache/LBP (mean/SD) 4.7 (11.2) 23.2 (30.0) < .001
Days with reduced work capacity (> 50%) within the last three months due to headache/LBP (mean/
SD)
13.7 (16.9) 41.9 (36.0) < .001
Days with reduced social capacity within
the last three months due to headache/LBP (mean/SD)
9.49 (14.5) 22.67 (27.7) < .001
Days with inability to do any housework due to headache/LBP (mean/SD) 7.6 (11.6) 20.56 (27.4) < .001
Days with reduced function(≥ 50%) in house work within the last three months due to headache/LBP
(mean/SD)
10.87 (14.9) 56.81 (31.4) < .001
Table 3 Course of disease and treatment history
Headache LBP p value
Duration of disease years; mean (SD) 16.28 (13) 12.03 (12.7) < .001
Duration of treatment years; mean (SD) 10.1 (10.1) 10.5 (11.5) n.s.
Duration of CAM treatment for headache or LBP years; mean (SD) 7.2 (7.3) 6.3 (14.7) n.s.
Days with analgesic medication per month; mean (SD) 8.4 (7.2) 21.1 (11.0) < .001
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sages, and thermotherapy are the most frequent CAM
therapies in headache and in reverse order for LBP. The
most frequently used CAM therapies in Germany are
exercise therapy, herbal medicine, hydrotherapy, medical
massage, homeopathic remedies and acupuncture [22].
Considering the different therapeutic impact of phy-
siotherapy in headache and LBP, physiotherapy was not
defined as a CAM modality. Some specific techniques
are recommended in treatment guidelines especially for
Table 4 Frequencies of used CAM treatments
Headache (n = 353) LBP (n = 177) p value
Pharmacological CAM
High-dose megavitamins; n (%) 32 (9.1) 40 (22.7) < .001
Herbal medicine; n (%) 24 (6.8) 23 (13.1) n.s.
Homeopathy; n (%) 100 (28.3) 21 (11.9) < .001
Non-pharmacological CAM
Transcutaneous electrical nerve stimulation (TENS); n (%) 81 (22.9) 28 (15.8) n.s.
Thermotherapy (Fango); n (%) 103 (29.2) 137 (77.4) < .001
Acupuncture; n (%) 252 (71.4) 91 (51.4) < .001
Manual Therapy; n (%)
b 66 (18.7) 80 (45.2) < .001
Massages; n (%) 199 (56.4) 111 (62.7) n.s.
Magnetic field; n (%) 0 29 (16.4) < .001
Kinesio-taping; n (%)
a 10 (5.6)
Osteopathy; n (%)
a 10 (5.6)
Traditional Chinese medicine; n (%) 41 (11.6) 15 (8.5) n.s.
Others
b 46 (13) 31 (17.5) n.s.
a not applicable
b (e.g. diets, music therapy, oxygen therapy, psychofonia, meditation, climate therapy); n (%)
Figure 1 Motivation for CAM use among headache and LBP patients. Reasons for CAM use given by patients with headache and LBP are
shown. LBP: low back pain; *significant; c2 tests was run, multiple answers were appropriate.
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endurance sports is weak in headache treatment while
more evidence is found in LBP [6,26,27]. There is no
evidence supporting the use of transcutaneous electrical
nerve stimulation (TENS) in headache or LBP therapy
[5,28].
Understanding the high frequency of CAM use leads to
an analysis of motivations and barriers to treatment. Prior
CAM use was associated with current CAM use, showing
the adherence to previous experience and behavior. ‘Lack
of effectiveness of conventional treatment’ was given as
the strongest motivational reason for CAM treatment.
This is not surprising regarding clinical trials in headache
prophylaxis showing a 50% reduction of headache days in
only half of the patients. Similarly discouraging data are
reported for treatment of LBP. Effects of acute pain medi-
cation as well as of prophylactic medication were esti-
mated only as “moderate” in a recent review [27].
Contradicting this, dissatisfaction with conventional treat-
ment was not significantly associated with more frequent
CAM use in our study. However, patients expect an
improvement in the chronic condition. CAM therapies are
estimated as helpful by most patients and they would like
to have more information on CAM and would appreciate
prescriptions of CAM [22]. Headache patients raised three
times more concerns about permanent conventional drug
intake than LBP patients. This could be a consequence of
the longer duration of disease and repeated frustration
about past treatments. Notably, concerns about drugs are
four times more frequent in both groups than concerns
resulting from bad experience with conventional medical
practitioners.
In addition to the motivational factors, barriers for
CAM use could be asked among the patients who had
no experience with CAM. In the present study, the sub-
stantial number of patients offering no declaration of
the given reasons in the questionnaire is striking (21.5%
in headache; 82.4% in LBP), implying that possible rea-
sons for not having used CAM are not sufficiently
shown in the predetermined answer alternatives.
Apprehension of side effects is more important for
headache than for LBP patients, but is a substantially
itemized pro for CAM in both. This reflects the general
assumption of many patients that CAM has no or fewer
side effects. However, numerous herbal remedies have a
potentially sensitizing capacity for allergic contact der-
matitis and lead to IgE-mediated clinical symptoms or
may have carcinogenic properties. Interaction between
conventional drug treatment and CAM has to be con-
sidered. Injuries resulting in pneumothorax, cardiac
tamponade or spinal injury and infectious complications
are rare side effect of acupuncture [29].
To be active against the pain condition is reported as a
motivation for CAM therapy more frequently in headache
than in LBP patients. Furthermore, the wish to “leave
nothing undone” was displayed clearly in both groups.
The patients’ activities in this point may reflect the pain
intensity and frequency, the high burden of disease and
unsatisfactory treatment experiences. However, no signifi-
cant difference was found between CAM and non-CAM
users regarding satisfaction with conventional pain treat-
ment. This contradicts studies revealing an association
between treatment satisfaction and search for CAM [30].
An important point is the advice of other persons to
use CAM, which increases CAM use in both LBP
(32.2%) and headache (40%) patients. This may corre-
spond to family traditions or experience relayed from
friends. Only a small group of patients gives other rea-
sons for CAM treatment, reflecting the accuracy of the
questionnaire to capture the relevant information. Other
sources of information about CAM treatment are televi-
sion, newspapers and internet. The gathering of more
information from media coverage by the headache
patients may reflect the lower mean age.
Cost and reimbursement from insurance may influ-
ence CAM use, too. However, only a small portion of
the non-users among the headache (12.7%) and LBP
(5.9%) patients give the cost as a barrier against CAM
use. The situation of the statutory health insurance sys-
tem in Germany should also be considered. For regular
treatment, all costs are paid by the insurance directly
without the need for prior administrative decision
Table 6 Satisfaction with current conventional therapy
Measure Non-CAM (n = 96) CAM (n = 530) p value
Satisfaction with conventional medical therapy n.s
Very satisfied; n (%) 22 (28.9) 139 (29.4)
Moderately satisfied; n (%) 30 (39.5) 229 (48.5)
Not satisfied; n (%) 24 (31.6) 104 (22.0)
Table 5 Additional lifestyle information and factors
which may influence CAM use
Non-CAM CAM p value
Never drinking alcohol; n (%) 19 (20.7) 173 (33.8) n.s
Non-smoker; n (%) 47 (50.5) 374 (73.2) < .001
Sports n.s
-never; n (%)
-once or more a week; n (%)
31 (36.5)
54 (63.5)
142 (29.5)
340 (70.5)
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puncture in LBP but not in headache).
It might be helpful to ask patients about current CAM
use to avoid side effects and pharmacological interac-
tions. Their understanding of their treatment wishes and
beliefs should also be taken into consideration. CAM
therapies are popular especially among general practi-
tioners in Germany; therefore it is not surprising that
71.7% of the headache and 77.4% of the LBP patients
had talked about CAM use with their physicians.
As a limitation, the survey was performed among
headache outpatients treated in tertiary centers and
among inpatients with LBP. This population may be
characterized through higher disability and burden of
disease compared to patients of the general population.
This could influence the frequency and motivation of
CAM use. In future studies, we suggest using a more
strict definition of CAM therapies and asking exactly
t h es a m eq u e s t i o n si nc o n d itions to be compared. The
specific healthcare system should be considered in com-
paring results from different countries. Reimbursement
by the health care insurance might be important as an
additional predictor of CAM use.
Conclusion
Despite disease-specific differences in LBP and in head-
ache patients, both groups show high use of CAM mostly
in conjunction with conventional treatment with only
slight specific differences in preferred methods and moti-
vation for CAM use. This may reflect deficits and unful-
filled goals in conventional treatment of chronic diseases
associated with pain conditions. Clinicians should ask
patients about their CAM use, discussing benefits and pos-
sible risks. Understanding motivation for CAM treatment
is important for communication with patients about CAM
and conventional treatment, because motivation derives
from wishes for non-pharmacological treatment, to be
more involved in treatment and avoid side effects. Maybe
CAM can decrease the gap between patients’ expectations
on pain therapy and current treatment reality, keeping in
mind that headache and LBP are chronic diseases with
high burden on daily life for many people.
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